A new trading day began on Friday, with Pacific Biosciences of California Inc (NASDAQ: PACB) stock price down -4.16% from the previous day of trading, before settling in for the closing price of $2.05. PACB’s price has ranged from $1.16 to $10.65 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 24.48%. Meanwhile, its annual earnings per share averaged -12.49%. With a float of $241.81 million, this company’s outstanding shares have now reached $273.81 million.
Considering the fact that the conglomerate employs 796 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 18.12%, operating margin of -215.33%, and the pretax margin is -228.11%.
Pacific Biosciences of California Inc (PACB) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Pacific Biosciences of California Inc is 11.70%, while institutional ownership is 83.15%. The most recent insider transaction that took place on Sep 30 ’24, was worth 34,065. In this transaction an insider of this company sold 19,782 shares at a rate of $1.72, taking the stock ownership to the 695,654 shares. Before that another transaction happened on Sep 30 ’24, when Company’s Officer proposed sale 19,782 for $1.72, making the entire transaction worth $34,061.
Pacific Biosciences of California Inc (PACB) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -12.49% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -1.00% during the next five years compared to -9.76% drop over the previous five years of trading.
Pacific Biosciences of California Inc (NASDAQ: PACB) Trading Performance Indicators
Here are Pacific Biosciences of California Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 8.64. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.46, a number that is poised to hit -0.20 in the next quarter and is forecasted to reach -0.69 in one year’s time.
Technical Analysis of Pacific Biosciences of California Inc (PACB)
Compared to the last year’s volume of 9.65 million, its volume of 9.8 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 44.74%. Additionally, its Average True Range was 0.22.
During the past 100 days, Pacific Biosciences of California Inc’s (PACB) raw stochastic average was set at 47.59%, which indicates a significant increase from 30.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 99.44% in the past 14 days, which was lower than the 110.83% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.9792, while its 200-day Moving Average is $2.0869. Nevertheless, the first resistance level for the watch stands at $2.0667 in the near term. At $2.1733, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.2667. If the price goes on to break the first support level at $1.8667, it is likely to go to the next support level at $1.7733. Now, if the price goes above the second support level, the third support stands at $1.6667.
Pacific Biosciences of California Inc (NASDAQ: PACB) Key Stats
With a market capitalization of 514.46 million, the company has a total of 273,864K Shares Outstanding. Currently, annual sales are 200,520 K while annual income is -306,740 K. The company’s previous quarter sales were 39,970 K while its latest quarter income was -60,730 K.
